Papilloma in the nasal cavity and paranasal sinuses is one of the common benign tumors of the nose, which can be divided into inverted type, exophytic type and eosinophil type. Among them, inverted papilloma accounts for about 70% to 86% of nasal cavity and paranasal sinus papilloma, and about 0.5% to 4% of all nasal cavity and paranasal sinus tumors. Inverted papilloma has the characteristics of local invasive growth and easy recurrence, and 10%-15% of inverted papilloma will become malignant. The treatment is based on extended surgical resection. From 2014 to 2018, the Department of Rhinology of our hospital admitted 609 patients with nasal cavity and paranasal sinus papilloma. The number of cases ranked first in the world. We have accumulated rich experience in endoscopic sinus surgery. The diagnosis/treatment model and curative effect have reached the world-class level. Past experience summary has been published in Histopathology, Acta Otolaryngol, Am J Rhinol Allergy, Eur Arch Otorhinolaryngol and other magazines.
In April 2021, Fudan EENT Nasal Cavity and Sinus Papilloma Subspecialty was officially established. The subspecialty is headed by young skull base surgeon Yu Huapeng. Professor Wang Dehui and Professor Yu Hongmeng personally participated in the guidance. The backbone members include Fudan EENT Rhinology and Skull Base Surgeons. Fudan EENT nasal cavity and sinus papilloma subspecialty is an important part of the construction of "extensive rhinology, subspecialty", the purpose is to strengthen the direct connection between diseases and specialties, and to provide patients with more professional and accurate "package" diagnosis, treatment, and follow-up programs.